BACKGROUND AND OBJECTIVES
The use antifungals (AF) has increased these last years world wide. We decided to do an audit of antifungals prescriptions in our teaching hospital (953 beds). Our study evaluated the appropriateness AF prescribing according to 5 identified quality criteria; indication, choice of molecule, correct dosing , loading dose and duration. Additionally, we evaluated notification in medical charts for indications which is recognized as a quality indicator of antiinfective drugs prescribing 1 .
MATERIALS AND METHODS
Four point prevalence surveys (PPS) were undertaken prospectively during February 2014, March 2014, August 2014 and March 2015. The quality of treatments was assessed by an independant infectious disease specialist and two pharmacists according to standard guidelines. The percentage agreement with indication, dosage and duration of treatment was determined using an adaptation for antifungal drug use of a standardized method for antimicrobial drug use evaluation, developed by Gyssens et al 3 . The objective to make days of observation at the separate moments is to follow the evolution of the practices and the impact of the institutional recommendations on the prescription. RESULTS : Patients and units characteritics *Empirical (E) : the pathogen was unknown at the time of prescription and there was no microbiological confirmation *Directed (D) : the pathogen was suspected in the beginning, later identified *Targeted (T) : the pathogen was known 
RESULTS : Indications of Antifungals use

CONCLUSIONS
The study identified gaps in quality of antifungals prescriptions as only 56,5 % of prescriptions were adequate according to all criteria. But in general, when compared to the literature quality of prescription was globally the same : 54% at teaching hospital of Besançon (4) and 57% at a teaching hospital of Grenoble (5) . Moreover, the lack of notification for indications impairs continuity of care. Median percentage reached 64,8 % with 45,4% total notification (name of AF + indication). This result is the same of notification in previous antibiotic audit done in our hospital in 2010 but it's lower than European percentages of 76% (1) or 80% (2) .
In our current study we were not able to analyze per day of observation because last guidelines was implemented in hematology in September, 2014. The only day after the implementation is the 4th day in our sample (in March 31st). To complete our study, it would be necessary to make 2 -3 new days of observation at the end of year 2015 to verify change of behaviors (in hematology unit). Given the average duration of the AF treatment, we notice that the first 2 days of observation are too close. What has for consequences that 5 identical patients find themselves in day 1 and day 2. 
